2010/06/22 by Markus Kraemer, J. Uekermann, Jens Wiltfang +1 · 1 citation
Medicine · Psychology · #Attention Deficit Hyperactivity Disorder #Treatment of Major Depression #Bipolar Disorder and Treatment #Methylphenidate #Psychosis #Attention deficit hyperactivity disorder #Stimulant #Psychiatry #Schizophrenia (object-oriented programming) #Addiction #Attention deficit disorder #Vulnerability (computing) #Psychology #Medicine #Pediatrics
paper · doi:10.1097/wnf.0b013e3181e29174
openalex publication_date 2010/06/22 · openalex created_date 2016/06/24 · openalex updated_date 2026/07/30
OBJECTIVE: We present 3 new cases of psychotic symptoms in patients with adult attention-deficit/hyperactivity disorder while regularly treated with a stimulant therapy with methylphenidate. METHODS: Existing literature about this theme is reviewed, and potential mechanisms are discussed. RESULTS AND CONCLUSIONS: Medication with methylphenidate should be avoided in patients with vulnerability to schizophrenia and in drug addiction, but reported cases without these risk factors demonstrate that a careful and regular psychiatric monitoring is essential in all patients treated with methylphenidate.